Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mei-Kwan Yau

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Journal of Medicinal Chemistry|July 31, 2013
Toward drugs for protease-activated receptor 2 (PAR2)Mei-Kwan Yau, Ligong Liu, David P Fairlie
Expert Opinion on Therapeutic Patents|March 4, 2016
Protease activated receptor 2 (PAR2) modulators: a patent review (2010-2015)Mei-Kwan Yau, Junxian Lim, Ligong Liu, et al.
Angewandte Chemie (International Ed. in English)|October 30, 2021
Transport of Molecular Cargo by Interaction with Virus-Like Particle RNASoumen Das, Mei-Kwan Yau, Jeffery Noble, et al.
Journal of the American Chemical Society|August 8, 2014
Stereoelectronic effects dictate molecular conformation and biological function of heterocyclic amidesRobert C Reid, Mei-Kwan Yau, Ranee Singh, et al.
Organic Letters|April 14, 2021
The Influence of Substitution on Thiol-Induced Oxanorbornadiene FragmentationLucrezia De Pascalis, Mei-Kwan Yau, Dennis Svatunek, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 22, 2017
A Potent Antagonist of Protease-Activated Receptor 2 That Inhibits Multiple Signaling Functions in Human Cancer CellsYuhong Jiang, Mei-Kwan Yau, Junxian Lim, et al.
Journal of Medicinal Chemistry|September 27, 2014
Potent heterocyclic ligands for human complement c3a receptorRobert C Reid, Mei-Kwan Yau, Ranee Singh, et al.
Pharmacology & Therapeutics|February 1, 2011
Structure, function and pathophysiology of protease activated receptorsMark N Adams, Rithwik Ramachandran, Mei-Kwan Yau, et al.
Journal of Chemical Information and Modeling|May 23, 2015
Three Homology Models of PAR2 Derived from Different Templates: Application to Antagonist DiscoverySamuel R Perry, Weijun Xu, Anna Wirija, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|August 22, 2013
Diet-induced obesity, adipose inflammation, and metabolic dysfunction correlating with PAR2 expression are attenuated by PAR2 antagonismJunxian Lim, Abishek Iyer, Ligong Liu, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Journal of Medicinal Chemistry|July 31, 2013
Toward drugs for protease-activated receptor 2 (PAR2)Mei-Kwan Yau, Ligong Liu, David P Fairlie
Expert Opinion on Therapeutic Patents|March 4, 2016
Protease activated receptor 2 (PAR2) modulators: a patent review (2010-2015)Mei-Kwan Yau, Junxian Lim, Ligong Liu, et al.
Angewandte Chemie (International Ed. in English)|October 30, 2021
Transport of Molecular Cargo by Interaction with Virus-Like Particle RNASoumen Das, Mei-Kwan Yau, Jeffery Noble, et al.
Journal of the American Chemical Society|August 8, 2014
Stereoelectronic effects dictate molecular conformation and biological function of heterocyclic amidesRobert C Reid, Mei-Kwan Yau, Ranee Singh, et al.
Organic Letters|April 14, 2021
The Influence of Substitution on Thiol-Induced Oxanorbornadiene FragmentationLucrezia De Pascalis, Mei-Kwan Yau, Dennis Svatunek, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 22, 2017
A Potent Antagonist of Protease-Activated Receptor 2 That Inhibits Multiple Signaling Functions in Human Cancer CellsYuhong Jiang, Mei-Kwan Yau, Junxian Lim, et al.
Journal of Medicinal Chemistry|September 27, 2014
Potent heterocyclic ligands for human complement c3a receptorRobert C Reid, Mei-Kwan Yau, Ranee Singh, et al.
Pharmacology & Therapeutics|February 1, 2011
Structure, function and pathophysiology of protease activated receptorsMark N Adams, Rithwik Ramachandran, Mei-Kwan Yau, et al.
Journal of Chemical Information and Modeling|May 23, 2015
Three Homology Models of PAR2 Derived from Different Templates: Application to Antagonist DiscoverySamuel R Perry, Weijun Xu, Anna Wirija, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|August 22, 2013
Diet-induced obesity, adipose inflammation, and metabolic dysfunction correlating with PAR2 expression are attenuated by PAR2 antagonismJunxian Lim, Abishek Iyer, Ligong Liu, et al.
Pageof 3